New initiative seeks $500m to commercialize Israeli life science...

The Israel National Biotech Innovation Center is a new initiative seeking to raise $500 million to commercialize Israeli life sciences.

It is led by former Bristol Myers Squibb executive Samuel Moed and Compugen chairperson Dr. Anat Cohen-Dayag.

PRO: see who's reacting and what you're missing. See the whole picture →